Nelson the swine, said weeks not dayππ he lied ππ23 Jul 2024 07:54
Nicholas Nelson, Chairman, Graft Polymer, commented:
"Today's Collaboration Agreement aligns perfectly with Graft Polymer's objective of leveraging its existing drug delivery system to enhance the effectiveness of therapeutic treatments.
"We believe our investment and expertise will promote the success of Awakn's novel aminoindane NCE programme, potentially making a substantial positive impact on the treatment of trauma related mental health disorders. We look forward to updating the market on developments in the weeks ahead